STOCK TITAN

Tandem Diabetes (TNDM) CTO reports RSU vesting, ESPP share purchase and tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Tandem Diabetes Care EVP & Chief Technology Officer Rick Carpenter reported routine equity compensation activity involving restricted stock units and an employee stock purchase plan. On May 15, 2026, he acquired 1,336 shares of common stock at $10.90 through the company’s employee stock purchase plan and vested RSUs that converted into shares.

To cover tax obligations on these RSU vestings, 4,466 shares were withheld by the company at $12.82 per share, and footnotes clarify that no shares were sold in the market. After all transactions, Carpenter directly held 25,979 shares of Tandem Diabetes Care common stock.

Positive

  • None.

Negative

  • None.
Insider Carpenter Rick
Role EVP & Chief Technology Officer
Type Security Shares Price Value
Exercise Restricted Stock Unit 1,437 $0.00 --
Exercise Restricted Stock Unit 898 $0.00 --
Exercise Restricted Stock Unit 6,439 $0.00 --
Exercise Common Stock 1,437 $0.00 --
Tax Withholding Common Stock 732 $12.82 $9K
Exercise Common Stock 898 $0.00 --
Tax Withholding Common Stock 457 $12.82 $6K
Exercise Common Stock 6,439 $0.00 --
Tax Withholding Common Stock 3,277 $12.82 $42K
Grant/Award Common Stock 1,336 $10.90 $15K
Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct); Common Stock — 26,711 shares (Direct)
Footnotes (1)
  1. Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2025, through May 15, 2026. This transaction is also exempt under Rule 16b-3(c). Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Awarded on May 23, 2024 pursuant to the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Awarded on May 30, 2025 pursuant to the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
ESPP acquisition 1,336 shares at $10.90 Common stock acquired under Employee Stock Purchase Plan on May 15, 2026
Tax withholding shares 4,466 shares at $12.82 Shares withheld by company to satisfy RSU-related tax obligations
RSU conversions 8,774 shares Total common shares from RSU exercises (M-code transactions) on May 15, 2026
Post-transaction holdings 25,979 shares Directly held Tandem Diabetes Care common stock after all reported transactions
Exercise transactions 3 entries, 8,774 shares Derivative exercise/conversion count and shares per transactionSummary
Tax-withholding entries 3 entries, 4,466 shares F-code dispositions for payment of tax liability by delivering securities
Restricted Stock Unit financial
"security_title: "Restricted Stock Unit" and footnote describing each RSU as a contingent right to receive stock or cash"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Employee Stock Purchase Plan financial
"acquisition of shares pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP)"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
tax withholding requirements financial
"Shares withheld by Tandem Diabetes Care Inc. to satisfy tax withholding requirements on vesting of restricted stock units (RSU)."
Rule 16b-3(c) regulatory
"This transaction is also exempt under Rule 16b-3(c)."
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
Long-Term Incentive Plan financial
"Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended."
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transactions did TNDM executive Rick Carpenter report?

Rick Carpenter reported routine equity compensation activity, including RSU vesting and an ESPP purchase. He acquired common shares through plan mechanisms and had additional shares withheld by the company solely to satisfy tax obligations tied to those vestings.

Did the Tandem Diabetes Care (TNDM) executive sell any shares in this Form 4?

No, the filing states that no shares were sold. Shares labeled as dispositions were withheld by Tandem Diabetes Care to satisfy tax withholding requirements related to restricted stock unit vesting, rather than open-market or discretionary share sales.

How many Tandem Diabetes Care (TNDM) shares does Rick Carpenter hold after the transactions?

After the reported transactions, Rick Carpenter directly holds 25,979 shares of Tandem Diabetes Care common stock. This figure reflects the net result of RSU conversions, the ESPP acquisition, and shares withheld for tax obligations on the same date.

What is the size and price of Rick Carpenter’s ESPP acquisition of TNDM shares?

Rick Carpenter acquired 1,336 shares of Tandem Diabetes Care common stock at $10.90 per share under the company’s Employee Stock Purchase Plan for the purchase period from November 18, 2025 through May 15, 2026, as disclosed in the footnotes.

How many Tandem Diabetes Care (TNDM) shares were withheld for taxes in this Form 4?

A total of 4,466 shares of Tandem Diabetes Care common stock were withheld to cover tax obligations. These tax-withholding dispositions occurred at a reported price of $12.82 per share in connection with restricted stock unit vesting on May 15, 2026.

What RSU activity did Tandem Diabetes Care (TNDM) report for Rick Carpenter?

The filing shows multiple restricted stock unit conversions into common stock totaling 8,774 shares. These RSUs were granted under the 2023 Long-Term Incentive Plan and vested according to scheduled installments, with some of the resulting shares withheld to satisfy tax liabilities.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Carpenter Rick

(Last)(First)(Middle)
12400 HIGH BLUFF DRIVE

(Street)
SAN DIEGO CALIFORNIA 92130

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TANDEM DIABETES CARE INC [ TNDM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Chief Technology Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026M1,437A$026,711D
Common Stock05/15/2026F(1)732D$12.8225,979D
Common Stock05/15/2026M898A$026,877D
Common Stock05/15/2026F(1)457D$12.8226,420D
Common Stock05/15/2026M6,439A$032,859D
Common Stock05/15/2026F(1)3,277D$12.8229,582D
Common Stock05/15/2026A(2)1,336A$10.930,918D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(3)(4)05/15/2026M1,437 (5) (5)Common Stock1,437$00D
Restricted Stock Unit(6)(4)05/15/2026M898 (7) (7)Common Stock898$03,589D
Restricted Stock Unit(8)(4)05/15/2026M6,439 (9) (9)Common Stock6,439$012,878D
Explanation of Responses:
1. Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
2. The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2025, through May 15, 2026. This transaction is also exempt under Rule 16b-3(c).
3. Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
4. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
5. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
6. Awarded on May 23, 2024 pursuant to the 2023 Plan.
7. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
8. Awarded on May 30, 2025 pursuant to the 2023 Plan.
9. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Remarks:
/s/ Shannon M. Hansen, Attorney-in-Fact for Rick A. Carpenter05/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)